Client Background

As the brand prepared for FDA approval of its flagship migraine therapy in early 2021, it aimed to leverage strong clinical results and a novel fast-acting nasal delivery to stand out in a crowded market. Despite promising science, success was not guaranteed in a category dominated by major players with celebrity-backed campaigns. To drive adoption, coverage, and adherence, the team sought a differentiated go-to-market strategy and engaged commercial partners to overcome competitive and channel challenges.

Launch Goals

• Drive adoption with a differentiated go-to-market strategy

• Secure coverage and ensure patient access

• Boost adherence for sustainable growth

The Challenge

To support a successful launch, they needed a partner that could help them:

1. Deliver a Modern Patient Access Experience Eliminate friction points with a seamless, digital-first experience for patients and HCPs.

2. Lay the Foundation for Covered Dispenses Partner with a company that could convert formulary placement into covered dispenses.

3. Generate Lasting HCP Loyalty Build awareness and confidence in adherence with effective support and ecommerce like home delivery.

4. Provide an Alternative to Retail Avoid prior authorization challenges in the retail channel that could threaten adoption and erode Gross to Net.

5. Gain Actionable Insights Leverage real-time data during the launch phase to adjust business rules and unlock  coverage and growth.

The Solution

The brand knew going it alone was risky and that legacy access partners couldn’t meet modern channel demands. Targeting a diverse patient population, they needed a solution that could tailor dispense workflows for Commercial, Government, and Uninsured patients. They chose PHIL as a partner due to our exceptional patient experience, integrated platform, and proven ability to drive new starts while converting formulary access into covered dispenses.

Together, we set out to support a successful launch by:

1. Simplify HCP & Patient Access Journey Enable easy ePrescribing within existing workflows, smartphone-based enrollment, and full script visibility throughout the journey.

2. Neutralize Prior Authorization Obstacles Use real-time benefits checks, parallel workflows, and prepopulated forms for easy and quick PA submissions.

3. Leverage Channel Data Analyze HCP, patient, and payer behavior to support obtainment of formulary and adjust business rules to facilitate improved access.

Partnering with PHIL to Commercialize Their Therapy

PHIL partnered with launch teams to implement a customized patient access program powered by its integrated platform—fully embedded in brand assets and launch-ready within weeks.

The launch solution included:

1. Seamless Digital Enrollment Patients enroll via text in minutes on their smartphone after receiving a prescription—often before leaving the doctor’s office.

2. Differentiated Dispense Workflows Tailored by insurance type, including uncovered options, patient assistance programs, and government waivers.

3. Intelligent Pharmacy Routing Prescriptions routed to pharmacies contracted with the patient’s insurance after eRx and benefit verification.

4. “1-Click” PA Submissions Platform auto-populates forms from eRx data for quick prior authorization and formulary exception submissions.

5. Simple Refills Patients opt into refill management and receive notifications to manage upcoming prescriptions.

6. Payer Coverage Data & Insights Manufacturers access real-time payer response data to inform market access strategies.

This solution helped the brand

The Results

The partnership with PHIL facilitated the conversion of formulary placement to covered dispenses positioning the brand for sustained growth.